Nguyen NH, et al. - In patients receiving medical treatment for inflammatory bowel diseases (IBD), researchers studied 30- and 90-day rates and causes of, risk factors for, and interventions to lessen hospital readmission through performing random effects meta-analysis. The final analysis included 17 cohort studies (6,324 patients) of IBD hospitalized adults receiving medical treatment, along with reported readmission rates with detailed chart review. Overall readmission rates of 30 and 90 days are 18.1% and 26.0% respectively for patients receiving medical treatment for IBD. IBD flare, infection, or complications from unplanned surgeries during hospitalizations were the most common reasons for readmission. Admission for pain control, need for total parenteral nutrition on discharge, and prior or unplanned surgery during admission were consistent risk factors for 30-day readmission. Interventional studies are required to decrease readmission risk.